跳至主要内容
临床试验/NCT04528043
NCT04528043已完成不适用

Infections and Colonization With the Third Group of Enterobacteriaceae in the Intensive Care Impact on the Mortality and Morbidity

Central Hospital, Nancy, France1 个研究点 分布在 1 个国家目标入组 179 人开始时间: 2017年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
179
试验地点
1
主要终点
all cause mortality

研究概览

简要总结

There is a lack of data whether colonization and infection with Enterobacteriaceae of the third group (EB3) affect the outcomes for ICU patients. This study evaluated the effects of EB3 colonization and infection on ICU mortality, ICU length of stay (LOS) and broad-spectrum antibiotic exposure. We focused on the sub type Enterobacter regarding its a priori higher risk of resistance.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •adults critically ill patients admitted to the the participating ICUs during the study period
  • •with colonization and/or infection with a third group enterobacteriacea
  • •and with a lenght of stay > 24h

排除标准

  • •minors patients
  • •lenght of stay < 24h

结局指标

主要结局

all cause mortality

时间窗: Day 180

Evaluation of the impact of colonization and/or infection with third group enterobacteriaceae on mortality during hospitalization and up to 180 day

次要结局

  • Resistance strains of sub type enterobacter(DAY 90)

研究者

发起方
Central Hospital, Nancy, France
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验